Vadimezan Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00863733Study of DMXAA (Now Known as ASA404) in Solid Tumors